Clinical Trials Logo

Bulky Tumor clinical trials

View clinical trials related to Bulky Tumor.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04587817 Not yet recruiting - Immunotherapy Clinical Trials

Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors

Start date: October 15, 2020
Phase:
Study type: Observational

This trial will explore effectiveness and safety using the combination therapy of camrelizumab and hyperfractionated radiotherapy in patients with massive tumor including non-small cell lung cancer, soft tissue sarcoma or urothelial carcinoma. Hypofractionation which represented by stereotactic body radiation therapy (SBRT) is a technique that delivers higher daily doses of radiation over a shorter period of time. This trial will also observe the index which can influencing the curative effect of hyperfractionated radiotherapy combined with immunotherapy.